CASI Pharmaceuticals, Inc. (CASIF) stock
CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
$0.10+0.00 (0.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
CASI Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
CASI Pharmaceuticals's total assets was $25.65M at Dec 31, 2025. For fiscal 2025 it was $25.65M, down 52.2% from the year before. The highest annual figure on record is $138.30M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.65M | -52.2% |
| FY2024 | Dec 31, 2024 | $53.67M | -28.7% |
| FY2023 | Dec 31, 2023 | $75.27M | -21.8% |
| FY2022 | Dec 31, 2022 | $96.23M | -30.4% |
| FY2021 | Dec 31, 2021 | $138.30M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $25.65M | -81.5% |
| Q4 FY2024 | Dec 31, 2024 | $53.67M | – |
| Q4 FY2023 | Dec 31, 2023 | $75.27M | – |
| Q4 FY2022 | Dec 31, 2022 | $96.23M | – |
| Q4 FY2021 | Dec 31, 2021 | $138.30M | – |
See a number that looks wrong?